Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 7, 2012 - Issue 8
Submit an article Journal homepage
255
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Understanding and creating value from open source drug discovery for neglected tropical diseases

Minna AllarakhiaUniversity of Waterloo, Faculty Department of Management Sciences, Waterloo, Ontario, Canada+647 988 9843; +877 524 6249; [email protected]
&
Larry AjuwonGenzyme Europe, Naarden, The Netherlands
(Senior Outsourcing Manager)
Pages 643-657 | Published online: 02 Jun 2012

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Temmy Sunyoto. (2020) Partnerships for better neglected disease drug discovery and development: how have we fared?. Expert Opinion on Drug Discovery 15:5, pages 531-537.
Read now
Minna Allarakhia. (2013) Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases. Drug Design, Development and Therapy 7, pages 753-766.
Read now

Articles from other publishers (4)

Soumendranath Bhakat. (2021) Pepsin-like aspartic proteases (PAPs) as model systems for combining biomolecular simulation with biophysical experiments. RSC Advances 11:18, pages 11026-11047.
Crossref
Joshua M. Pearce. (2020) Distributed Manufacturing of Open Source Medical Hardware for Pandemics. Journal of Manufacturing and Materials Processing 4:2, pages 49.
Crossref
P.W. Denny & P.G. Steel. (2015) Yeast as a Potential Vehicle for Neglected Tropical Disease Drug Discovery. SLAS Discovery 20:1, pages 56-63.
Crossref
J. L. NORCLIFFE, E. ALVAREZ-RUIZ, J. J. MARTIN-PLAZA, P. G. STEEL & P. W. DENNY. (2013) The utility of yeast as a tool for cell-based, target-directed high-throughput screening. Parasitology 141:1, pages 8-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.